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Large prospective, randomized trials now have
established the efficacy of carotid endarterectomy
(CEA) in the prevention of ischemic stroke among
both symptomatic1,2 and asymptomatic3 patients
with severe internal carotid artery stenoses. The
prevalence of stroke also is known to increase with
advancing age and becomes the second leading
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cause of death by 85 years of age.4 Stroke prevention
among the elderly almost certainly will assume even
more importance in the future because current pre-
dictions indicate that the proportion of the United
States population aged 75 years or older will double
from approximately 5% in 1990 to nearly 10% by
2030.5-7
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Purpose: This study was undertaken to determine the safety and efficacy of carotid
endarterectomy (CEA) in the octogenarian population at the Cleveland Clinic.
Methods: From 1989 to 1995, 182 CEAs were performed among 167 octogenarians (98
men, 69 women) with a mean age of 83 years (median, 83 years; range, 80 to 93 years).
One hundred procedures (55%) were performed for severe asymptomatic stenosis,
whereas 48 (26%) were performed for hemispheric transient ischemic attacks (TIAs) or
amaurosis fugax, 24 (13%) for prior stroke, and 10 (5%) for vertebrobasilar symptoms.
Thirteen CEAs (7%) were combined with myocardial revascularization, and another five
(3%) represented carotid reoperations. Nine arteriotomies (5%) were closed primarily,
whereas the remaining 173 (95%) were repaired using either vein patch angioplasty
(141, 77%) or synthetic patches (32, 18%). Two patients were lost to follow-up, but late
information was available for 165 patients (180 operations) at a mean interval of 2.7
years (median, 2.4 years; maximum, 7.4 years).
Results: Considering all 182 procedures, there were five early (<30 days) postoperative
neurologic events (2.7%), including three strokes (1.6%) and two TIAs (1.1%). An addi-
tional 15 neurologic events occurred during the late follow-up period, consisting of 11
strokes (6.1%) and four TIAs (2.2%). The Kaplan-Meier estimated 5-year rate of free-
dom from stroke was 85% (95% confidence interval [CI], 77% to 93%). There was one
early postoperative death (0.6%) of cardiac complications 9 days after CEA. The esti-
mated 5-year survival rate was 45% (95% CI, 33% to 57%), and the 5-year stroke-free
survival rate was 42% (95% CI, 30% to 53%). Multivariable analysis yielded age at oper-
ation (p = 0.001), abnormal creatinine level (p = 0.025), and chronic obstructive pul-
monary disease (p = 0.019) as variables that significantly influenced the survival rate.
The presence of chronic obstructive pulmonary disease (p = 0.009) and, surprisingly, a
lesser degree of contralateral internal carotid stenosis (p = 0.003) were found to be sig-
nificantly associated with stroke after CEA. Causes of late death were cardiovascular in
16 patients (30%), unknown in 13 (24%), carcinoma in six (11%), stroke in six (11%),
and miscellaneous in 13 (24%).
Conclusions: We conclude that CEA may be safely performed in selected octogenarians
with carotid stenosis, and that the majority of these patients live the rest of their lives
free from stroke. Therefore, age alone should not exclude otherwise-qualified candidates
from consideration for CEA. (J Vasc Surg 1998;27:860-71.)
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Despite these observations, the advisability of
CEA in very elderly patients remains controversial.
Although some authors have reported postoperative
mortality and stroke rates after CEA in octogenari-
ans that compare favorably with those for younger
patients,8-14 patients more than 79 years of age were
excluded from randomization in both the North
American Symptomatic Carotid Endarterectomy
Trial (NASCET) and the Asymptomatic Carotid
Atherosclerosis Study (ACAS).3,11 Furthermore,
others have suggested either that advanced age is
associated with an increased mortality rate after
CEA15,16 or that CEA may not be cost-effective in
patients over 75 years of age.17
Current limitations concerning the efficient, yet
compassionate use of diminishing health care
resources have generated reasonable concerns
regarding the long-term benefits of CEA in octo-
genarians. Consequently, the present study was
undertaken to determine the postoperative mortali-
ty and stroke rates associated with CEA in octoge-
narians at our own center, to document the late 
survival and stroke rates in these patients, and to
identify clinical factors that may influence their ulti-
mate outcome.
PATIENTS AND METHODS
We collected retrospective data from the hospital
records of 167 consecutive patients who underwent
182 CEAs at the age of 80 years or older from Jan-
uary 1989 through December 1995 (Table I).
Long-term information was obtained during subse-
quent office visits or by telephone contact with the
patients, their immediate families, or their local
physicians. End points were defined as death or
recent follow-up within 6 months of study closure.
In addition to death, outcome variables included
transient ischemic attack (TIA) or stroke occurring
either in the perioperative period or during late sur-
veillance. Follow-up was complete for 165 patients,
representing 180 operations. The remaining two
patients were considered lost at the time of hospital
discharge, each on the fourth postoperative day. The
median follow-up period for the survivors was 2.2
years (mean, 2.7 years; maximum, 7.4 years).
The study group consisted of 98 men and 69
women, with a mean age of 83 years (median, 83
years; range, 80 to 93 years) at the time of their
operations. One hundred nine patients (66%) had
clinical evidence of coronary artery disease—defined
as a convincing history of prior myocardial infarction
or angina—or either Q-waves or ischemic ST-T wave
changes on a 12-lead electrocardiogram. One hun-
dred twenty-seven patients (77%) had hypertension,
22 (13%) had diabetes, 24 (15%) had a history of
congestive heart failure, and 19 (12%) had chronic
obstructive pulmonary disease (COPD). Only 27
patients in this age group (17%) still smoked ciga-
rettes.
One hundred procedures (55%) were performed
for severe asymptomatic stenosis, whereas 48 (26%)
were performed for hemispheric TIAs or amaurosis
fugax, 24 (13%) for prior stroke, and 10 (5%) for
vertebrobasilar symptoms. One hundred thirty-
seven procedures (75%) were elective, 39 (21%)
were semielective, and three (2%) were emergent.
The urgency of the remaining three operations (2%)
could not be determined. Thirteen CEAs (7%) were
combined with myocardial revascularization, and
another five (3%) represented carotid reoperations.
Nine arteriotomies (5%) were closed primarily,
whereas the remaining 173 (95%) were repaired
using either vein patch angioplasty (141, 77%) or
synthetic patches (32, 18%).
The degree of preoperative internal carotid
stenosis for the patients in this series was evaluated
by ultrasound scan, angiogram, or both and was
based on an estimation of the diameter of residual
lumen compared with that of the carotid bulb. By
this method, an angiographic stenosis resulting in
80% diameter reduction is equivalent to 60% steno-
sis by the NASCET criteria.18 The ultrasound crite-
ria for 80% to 99% internal carotid stenosis required
both a peak systolic velocity greater than 240
cm/sec and an end diastolic velocity greater than
135 cm/sec. One hundred fifty-five procedures
(85%) were performed for 80% to 99% stenosis, 20
(11%) for 60% to 79% stenosis, five (3%) for 40% to
59% stenosis, two (1%) for 20% to 39% stenosis, and
none for 0% to 19% stenosis. Sixteen of the con-
tralateral internal carotid arteries (9%) were found to
be occluded, 29 (16%) had 80% to 99% stenosis, 34
Table I. Proportion of CEAs performed on octo-
genarians at the Cleveland Clinic
Octogenarian Total carotid
Year operations operations %
1989 26 317 8.2
1990 14 304 4.6
1991 26 300 8.7
1992 28 342 8.2
1993 25 313 8.0
1994 25 295 8.5
1995 38 365 10.4
Total 182 2236 8.1
(19%) had 60% to 79% stenosis, 27 (15%) had 40%
to 59% stenosis, 34 (19%) had 20% to 39% stenosis,
and 41 (22%) had 0% to 19% stenosis by preopera-
tive ultrasound scan, angiogram, or both. One hun-
dred fifty-two carotid arteries (84%) were imaged
with both ultrasound and angiography, whereas 20
procedures (11%) were performed on the basis of
ultrasound alone and the remaining 10 (5%) on the
basis of angiography alone. For purpose of analysis,
angiography results were used when available; oth-
erwise, ultrasound data were used.
A total of 56 patients (34%) in this series had at
some time undergone a myocardial revascularization
procedure. Fifty-two patients (31%) underwent
coronary artery bypass grafting (CABG), and four
(2%) underwent transluminal coronary angioplasty.
Thirteen CEAs were performed as combined proce-
dures in conjunction with CABG, and two patients
underwent staged CABG after CEA. Nine com-
bined procedures were performed for asymptomatic
80% to 99% stenoses, whereas four were performed
to correct symptomatic carotid lesions. The remain-
ing 41 cardiac procedures were performed before
the carotid operations at a median interval of 6.8
years before operation (mean, 7.3 years; range, 2
months to 22 years). Myocardial revascularization
procedures were performed within 6 months of
CEA in 17 patients, and within 1 year in 20; in the
remaining 36 patients, it was entirely incidental.
Kaplan-Meier estimates of survival distribution19
were generated for overall survival, freedom from
stroke, and for survival from stroke or death. The
association of baseline variables with the incidence of
stroke and death was tested by comparing the sur-
vival curves with a log-rank test if the variable was
categorical or by testing for association with a Cox
proportional hazards model if the variable was con-
tinuous. A significance level of a p value of 0.05 or
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less was used for each hypothesis. Risk factors that
influenced the rates of survival and freedom from
stroke were identified by univariate and multivari-
able analyses for the entire series. Survival analysis
using multivariable Cox proportional hazards mod-
els was used to evaluate the effects of individual vari-
ables on patient survival and freedom from stroke.
Risk ratios and their 95% confidence intervals (CIs)
indicate the risk of the outcome at any point in time
in the risk group compared with the reference
group. For continuous variables, the risk ratio com-
pares patients with a specified increment in the vari-
able. The c-index, an estimation of the degree of fit
of the model to the actual data, was calculated for
each multivariable Cox proportional hazards
model.20 SAS statistical software was used for all
analyses.21
We chose to draw comparisons of the 5-year esti-
mated survival rates of our study group with that of
the normal U.S. population from the U.S. census
data for 1991. The Census Bureau reports an
abridged life table for the overall population and by
gender, giving 5-year survival estimates for people
80 years of age.22 Because men outnumbered
women by a factor of 1.4 to 1 in our study, we cal-
culated an adjusted U.S. 5-year survival rate by tak-
ing a weighted average of the U.S. estimate for men
(60%) and women (72%) based on the population of
men (98 ÷ 167 = 0.59) and women (69 ÷ 167 =
0.41) in our study. The overall U.S. 5-year survival
rate for persons 80 years of age after gender-adjust-
ing to fit our study is 65%.
RESULTS
Early mortality and morbidity data. Consid-
ering all 182 procedures, there were five early (<30
days) postoperative neurologic events (2.7%),
including three strokes (1.6%) and two TIAs (1.1%).
There was one early postoperative (<30 days) death
(0.6%) from cardiac complications 9 days after CEA.
Two other deaths occurred at 38 days and 50 days,
respectively; one of these patients had pneumonia
and congestive heart failure, whereas the other had
respiratory failure and sepsis after a stroke. Both of
these additional deaths were causally related to the
preceding carotid operations, yielding an overall
perioperative mortality rate of 1.8% (three of 167)
for the entire series.
Contemporary, unpublished data from our
departmental registry concerning the early postoper-
ative mortality and stroke rates after CEA in patients
79 years of age or younger are summarized in Table
II. These figures reflect postoperative in-hospital
Table II. CEAs performed on patients <80 years of
age (Vascular Registry data; Jan. 1, 1989, to Dec.
31, 1995)
Total carotid Postoperative Postoperative 
Year arteries stroke % death %
1989 291 10 3.4 7 2.4
1990 290 6 2.1 1 0.3
1991 273 11 4.0 4 1.5
1992 314 8 2.5 4 1.3
1993 288 3 1.0 3 1.0
1994 269 5 1.9 2 0.7
1995 328 3 0.9 2 0.6
Total 2053 46 2.2 23 1.1
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(i.e., not 30-day) deaths and strokes at a time when
the median postoperative length of stay was 3 days
for the study interval. Nevertheless, the early post-
operative stroke rate for octogenarians (1.6%) still
was indistinguishable from that (2.2%) for younger
patients (p = 0.79, Fisher’s exact test). Similarly, nei-
ther the 30-day postoperative mortality rate (0.6%)
nor the total perioperative mortality rate (1.8%) for
octogenarians was significantly different from the
hospital mortality rate (1.1%) for younger patients 
(p = 0.99 and 0.44, respectively, Fisher’s exact test).
Data regarding the postoperative length of stay,
defined as the interval from the date of operation
to the date of hospital discharge, also are available
in our departmental registry for all patients who
underwent CEA from January 1990 through
December 1995. The postoperative length of hos-
pitalization for 1736 patients younger than 80
years of age (median, 3 days; mean, 5.6 days;
range, 0 to 200 days) was not different from that
for 155 octogenarians (median, 3 days; mean, 5.6
days; range, 0 to 55 days) who underwent CEA
during the same time study period (p = 0.09,
Wilcoxon rank-sum test).
Late survival and freedom from stroke. Late
survival data for all 167 patients are illustrated in
Fig. 1. The Kaplan-Meier 5-year survival rate for the
entire series was 45% (95% CI, 33% to 57%) and is
somewhat lower than the sex-adjusted 5-year sur-
vival rate (65%) for the normal U.S. population at
the age of 80 years.22 The probable causes for a total
of 54 late deaths are summarized in Table III.
An additional 15 neurologic events occurred
during the late follow-up period, consisting of 11
strokes (6.1%) and four TIAs (2.2%). As illustrated
in Figs. 2 and 3, the Kaplan-Meier estimated 5-year
rate of freedom from stroke was 85% (95% CI, 77%
to 93%), and the estimated 5-year stroke-free sur-
vival rate was 42% (95% CI, 30% to 53%).
Fig. 1. Cumulative survival rate (Kaplan-Meier method) for 167 octogenarians in the entire
series who underwent CEA.
Table III. Causes of 54 late (>30 days) postopera-
tive deaths





Renal failure 6 11
Respiratory 2 4
Miscellaneous 5 9
Gastrointestinal bleeding 1 2
Alzheimer’s disease 1 2
Parkinson’s disease 1 2
Ruptured aortic aneurysm 1 2
Complications of aortobifemoral bypass 1 2
Total 54 100
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Univariate and multivariable analyses. Risk fac-
tors that potentially influenced the rates of patient sur-
vival and freedom from both early and late stroke after
CEA were assessed with Cox proportional hazards
models.21 The clinical features considered and the
results of these analyses are summarized in Table IV.
Through univariate analysis, we identified the
presence of COPD (p = 0.027), and, surprisingly, a
Fig. 2. Cumulative rate of freedom from stroke (Kaplan-Meier method) for 167 octogenari-
ans in the entire series who underwent CEA.
Fig. 3. Cumulative stroke-free survival rate (Kaplan-Meier method) for 167 octogenarians in
the entire series who underwent CEA.
JOURNAL OF VASCULAR SURGERY
Volume 27, Number 5 O’Hara et al. 865
lesser degree of contralateral internal carotid steno-
sis (p = 0.004) as being significantly associated with
the risk of stroke at any time after CEA. We also
identified the presence of COPD (p = 0.035),
advancing age (p = 0.002), and abnormal serum cre-
atinine level (p = 0.036) as being significantly associ-
ated with death at any time after CEA (Table IV).
Multivariable analysis indicated the presence of
COPD (p = 0.009) and a lesser degree of contralat-
eral internal carotid artery stenosis (p = 0.003) as
variables significantly associated with the risk of
stroke after CEA (Table V). Multivariable analysis
also yielded age at operation (p = 0.001), abnormal
creatinine level (p = 0.025), and COPD (p = 0.019)
as variables that were significantly associated with
survival after CEA (Table VI). The c-index for each
multivariable Cox-regression model (0.79 for the
freedom from stroke model and 0.89 for the survival
model, respectively) demonstrated that each fits the
actual data reasonably well.20
In aggregate, these findings suggest that the
presence of COPD, each additional year of age, and
an abnormal preoperative serum creatinine level each
independently and significantly is associated with the
risk of dying at any time after CEA in this series. The
preoperative diagnosis of COPD also was associated
with an increased risk of stroke at any time after CEA.
According to the Cox proportional hazards model,
patients with contralateral internal carotid stenosis
were less likely to have strokes over the follow-up
interval, compared with those patients with a 20%
decrease in stenosis. The Kaplan-Meier 3-year survival
or stroke-free survival estimates for patients with and
without these clinical variables are summarized in
Table VII. Predicted estimates of cumulative survival
for patients with COPD, abnormal creatinine level,
and advancing age based on the Cox proportional
hazards model derived for the patients in this series are
depicted in Fig. 4. Similarly, a comparison of the
predicted estimates of cumulative freedom from
stroke for patients with COPD and variable degrees of
contralateral internal carotid stenosis based on the
Cox proportional hazards model for freedom from
stroke is presented in Fig. 5.
Table IV. Univariate tests for association with stroke and survival
Association with stroke Association with survival
Variable (risk group) Risk ratio (95% CI) p Risk ratio (95% CI) p
Gender (female) 0.79 (0.26 to 2.4) 0.67 0.70 (0.40 to 1.2) 0.20
Diabetes mellitus 0.93 (0.21 to 4.2) 0.92 0.80 (0.36 to 1.8) 0.58
Hypertension 0.81 (0.25 to 0.26) 0.72 1.2 (0.63 to 2.3) 0.57
Smoking 0.82 (0.18 to 3.7) 0.80 1.7 (0.94 to 3.2) 0.08
COPD 3.4 (1.1 to 11.0) 0.027† 2.1 (1.0 to 4.2) 0.035†
CAD 1.0 (0.33 to 3.0) 0.99 1.1 (0.62 to 1.9) 0.75
CHF 2.4 (0.75 to 7.7) 0.13 1.1 (0.57 to 2.3) 0.72
Symptoms [any of four below] 0.48 (0.16 to 1.4) 0.18 1.2 (0.68 to 2.0) 0.60
Amaurosis fugax 1.7 (0.37 to 7.4) 0.51 0.54 (0.17 to 1.7) 0.29
TIA 1.5 (0.46 to 4.7) 0.51 0.84 (0.44 to 1.6) 0.59
CVA 1.5 (0.33 to 6.7) 0.60 0.89 (0.35 to 2.2) 0.81
VBI 0.79 (0.10 to 6.1) 0.82 1.3 (0.54 to 3.0) 0.59
CABG 0.88 (0.28 to 2.8) 0.83 0.76 (0.41 to 1.4) 0.37
PTCA 3.8 (0.49 to 30.2) 0.17 1.3 (0.18 to 9.6) 0.79
Arteriotomy closure NA 0.16 NA 0.23
Side of surgery (right) 0.86 (0.30 to 2.5) 0.77 0.70 (0.41 to 1.2) 0.19
Urgency (nonelective) 1.1 (0.29 to 3.8) 0.94 1.3 (0.69 to 2.3) 0.46
Combined CABG/CEA 0.78 (0.10 to 6.0) 0.81 0.48 (0.15 to 1.5) 0.22
Age (for 10-year difference) 5.4 (0.80 to 36.6) 0.08 5.2 (1.8 to 14.8) 0.002†
Age group (quartiles) 1.3 (0.80 to 2.1) 0.70‡ 1.3 (1.0 to 1.7) 0.029
Creatinine level 0.99 (0.26 to 3.8) 0.99 2.2 (1.2 to 3.7) 0.009†
Quartiles 1.1 (0.65 to 1.8) 0.55‡ 1.3 (1.0 to 1.7) 0.05
Normal vs abnormal 0.82 (0.22 to 3.0) 0.76 1.8 (1.0 to 3.1) 0.036†
Ipsilateral stenosis (for 20% difference) 0.61 (0.30 to 1.2)* 0.16 0.84 (0.49 to 1.4)* 0.52
Contralateral stenosis (for 20% difference) 0.50 (0.31 to 0.80) 0.004† 0.92 (0.78 to 1.1)* 0.36
CAD, Coronary artery disease; CHF, congestive heart failure; CVA, cerebrovascular accident; PTCA, percutaneous transluminal coro-
nary angioplasty; VBI, vertebrobasilar insufficiency.
p value from Wald test of Cox proportional hazards model.
*Risk ratio for 20% difference in stenosis.
†p < 0.05; significant.
‡Test for linear trend over quartiles.
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Fig. 5. Graphic representation of comparison of predicted estimates of cumulative freedom
from stroke for patients with COPD and variable contralateral internal carotid stenosis based
on Cox proportional hazards model derived for patients in this series.
Fig. 4. Cumulative survival rate (Kaplan-Meier method) for 167 octogenarians in the entire
series who underwent CEA compared with predicted estimates of cumulative survival for
patients with COPD, abnormal creatinine level, and advancing age based on Cox proportion-
al hazards model derived for patients in this series.
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DISCUSSION
According to U.S. census data, life expectancy at
the age of 80 years is 7.2 years for men and 9.1 years
for women. By the age of 85 years, men can expect
5.3 additional years of life, and women, 6.5 years.23
For many patients, these additional years are rela-
tively healthy. However, stroke can be a devastating
event, particularly for the very elderly, resulting in
loss of function and independence.6,24 Furthermore,
the incidence of stroke is known to increase with
age, and it is the second leading cause of death
among patients aged 85 years or more.4,25,26
Because of the advancing age of the population, it is
likely that more elderly patients will be considered
for CEA in the foreseeable future.5-7 The economic
impact of stroke on an individual is difficult to define
with precision because of the many variables
involved, but it is intuitively clear that strokes are
very expensive.17
The octogenarians in our series had severe
carotid occlusive disease. Nearly all (96%) of the
internal carotid arteries operated on had at least 60%
to 79% stenosis documented by duplex ultrasound
or angiography, and 84% had ‡ 80% stenosis. Nearly
half were symptomatic, usually despite antithrom-
botic therapy. Based on an annual stroke risk of 2%
to 7% for asymptomatic internal carotid stenoses3,17
and 13% for symptomatic lesions,1 the annual risk of
stroke among the octogenarians in this series could
conservatively be estimated to be at least 10% with-
out surgical intervention.
The 30-day operative mortality rate for octoge-
Table V. Multivariable Cox model for association
with stroke after CEA (n = 158)
Association with stroke
Risk ratio Risk ratio 
Variable p reference (95% CI)*
COPD 0.009 No COPD 4.9 (1.5 to 16.3)
Contralateral 
stenosis 0.003 20% difference 0.47 (0.28 to 0.77)
*Risk of stroke at any point in time in risk group versus reference.
p value from Cox proportional hazards model, adjusting for other
variables in model.
Table VI. Multivariable Cox model for association
with survival after CEA (n = 155)
Association with survival
Risk ratio Risk ratio 
Variable p reference (95% CI)*
COPD 0.019 No COPD 2.3 (1.1 to 4.7)
Age 0.001 1-year increment 1.2 (1.08 to 1.37)
Creatinine 0.025 Normal 1.9 (1.1 to 3.5)
(normal vs 
abnormal [>1.4])
*Risk of death at any point in time in risk group versus reference.
p value from Cox proportional hazards model, adjusting for other
variables in model.
Table VII, A. Cumulative survival rate associated with clinical variables among octogenarians who under-
went CEA (univariate analysis)
Variable n Cumulative 3-year survival rate (%) CI (95%) p
Creatinine ≤1.4 121 78 69 to 87 0.036
Creatinine >1.4 42 65 49 to 82
Age by quartile 0.029
Age <81 yr 43 90 79 to 100
Age 81 to 83 yr 42 66 48 to 83
Age 83 to 85 yr 40 78 63 to 93
Age >85 yr 42 66 50 to 82
No COPD 139 80 72 to 88 0.035
COPD 19 44 17 to 72
Table VII, B. Cumulative rate of freedom from stroke associated with clinical variables among octogenari-
ans who underwent CEA (univariate analysis)
Variable n Cumulative 3-year stroke-free rate (%) CI (95%) p
No COPD 139 92 86 to 98 0.027
COPD 19 67 38 to 97
narians who underwent CEA was 0.6% in our series.
However, the true operative mortality rate is more
realistically 1.8% because two additional deaths, at
38 and 50 days after operation, were clearly related
to CEA. Nevertheless, the operative mortality rate
for octogenarians did not significantly differ from
that for younger patients who underwent CEA, an
observation reported elsewhere.10,11,27 Although
others have reported longer postoperative hospital-
ization intervals after CEA in the very elderly,11 we
were not able to demonstrate any difference in the
postoperative acute care hospitalization require-
ments between octogenarians and younger patients
in our series. Furthermore, the 30-day postoperative
stroke rate for octogenarians in our series (1.6%) also
was indistinguishable from the in-hospital stroke
rate for younger patients (2.2%), whose median
postoperative length of stay was 3 days during the
same study period. These observations support the
conclusion that the early results of CEA are as good
for properly selected octogenarians as they are for
younger patients.
Although the median age of the octogenarians in
our series was 83 years, their cumulative 5-year sur-
vival rate after CEA (45%) compares reasonably well
with the sex-adjusted 5-year survival rate (65%) esti-
mated for the normal U.S. population at the age of
80 years, a full 3 years younger. Furthermore, their
5-year rate of freedom from stroke was 85%, indicat-
ing that most of these patients lived the rest of their
lives without strokes. In fact, nearly half (42%) of
our patients lived an additional 5 stroke-free years
despite a median age of 83 years at the time of their
CEAs. The relationship of the late strokes to carotid
bifurcation disease remains uncertain because the
hemispheric distribution of all of the late strokes
could not be accurately determined. Moreover, the
observation that six late deaths (11%) were caused
by strokes underscores the fact that CEA cannot pre-
vent all late strokes, because some undoubtedly are
caused by other factors, such as cardiac arrhythmias
or hypertension. Finally, the causes of 13 late deaths
(24%) were undetermined, and therefore it is possi-
ble that some were stroke-related. Nevertheless,
these results, in a group of octogenarians conserva-
tively estimated to have an annual stroke risk of 10%,
support the efficacy of CEA in preventing late
strokes in selected surgical candidates.
In an attempt to develop guidelines for the selec-
tion of octogenarians who are likely to derive long-
term benefit from CEA, clinical variables associated
with rates of patient survival and freedom from
stroke were investigated using univariate and multi-
variable analysis. The preoperative clinical diagnosis
of COPD, an abnormal preoperative serum creati-
nine level, and advancing age each emerged as sig-
nificant independent variables associated with
declining late survival. To graphically demonstrate
the independent influence of these clinical factors,
predicted estimates of late survival after CEA for
four clinical scenarios were generated with a Cox
proportional hazards model (Fig. 4). For compari-
son, the observed survival data also are displayed and
indicate that most of the patients selected for CEA
were close to 80 years of age and had normal renal
and pulmonary function. To validate this model,
additional patients would need to be studied
prospectively to determine how well the predicted
data fit the observed results. Nonetheless, this
model can function as a useful complement to clini-
cal judgement.
The relationship of the clinical variables that
emerged from the univariate and multivariable
analysis as significant independent predictors of
stroke is less clear. Patients with the clinical diagno-
sis of COPD were found to be 4.9 times more like-
ly to have a stroke at any time after CEA than those
without COPD. Even more surprising is the obser-
vation that patients with a 20% increase in contralat-
eral internal carotid stenosis with respect to the
comparison group had 47% less risk of stroke at any
time after CEA. This conclusion seems counterintu-
itive and may represent an artifact of this series of
patients, or it may merely reflect how few strokes
occurred. Alternatively, it may reflect compensation
by collateral flow. Other investigators have reported
that stenosis of the contralateral internal carotid
artery was not associated with increased early post-
operative stroke risk at the time of CEA.28,29 A com-
parison of the predicted estimates of cumulative
freedom from stroke for patients with COPD and
variable contralateral internal carotid stenoses based
on the Cox proportional hazards model derived for
the patients in this series is shown in Fig. 5. Specu-
lation aside, a prospective validation of the model
would be required to confirm the clinical relevance
of these predictions.
CONCLUSION
Elderly patients with severe carotid disease toler-
ate CEA with excellent early and late results. Early
postoperative mortality rate, stroke risk, and postop-
erative length of hospital stay are indistinguishable
from younger patients in our experience. Late sur-
vival is favorably associated with a low preoperative
creatinine level, the absence of COPD, and a lower
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age. An increasing severity of contralateral carotid
stenosis probably does not increase the risk for early
or late stroke in this series. Late freedom from stroke
is unfavorably influenced by the presence of COPD.
We conclude that CEA is safe and clearly benefi-
cial in selected octogenarians with severe and/or
symptomatic internal carotid stenosis, and that the
majority of these patients live the rest of their lives
free from stroke. Repair of serious carotid occlusive
disease sufficiently enhances the long-term stroke-
free survival rate in octogenarians that age alone
should not be considered arbitrarily as a surgical
contraindication without further objective investiga-
tion. Although recommendations regarding which
elderly patients should or should not undergo CEA
should be individualized, our data suggest that
younger octogenarians with adequate pulmonary
and renal function are good, not poor, candidates
for CEA.
Becky Roberts helped to collect the data, and Kathy
Cotman, BA, assisted with the statistical analysis.
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Dr. Joseph R. Schneider (Evanston, Ill.). Dr.
O’Hara and his colleagues have presented the Cleveland
Clinic results for what is probably the largest, at least the
largest reported, series of octogenarians who underwent
carotid endarterectomy. This sample size provides good
statistical power and confidence in the reliability of their
data. Their early results were excellent, with a 1.6% peri-
operative stroke rate and a 1.8% perioperative mortality
rate, despite the fact that several operations were reopera-
tions, emergencies, or combined carotid endarterectomy
and coronary artery bypass graft efforts. The late results
present some fascinating questions.
When one considers the fact that 55% of their opera-
tions were performed on asymptomatic patients, the
assessment of the 5-year stroke-free estimate of 85%
becomes a little more difficult. As we know, the 5-year
stroke-free estimate was 89% in the medically treated
patients, which was virtually indistinguishable from the
rate for all patients in the present study. However, the
stroke-free estimates were substantially lower. That is,
more strokes occurred in the medical arms of the North
American Symptomatic Carotid Endarterectomy Trial
than in the European Carotid Surgery symptomatic trial.
For example, the 2-year stroke-free rate was estimated at
74% compared with the 70% to 99% stenosis stratum in
the medical arm of North American Symptomatic Carotid
Endarterectomy Trial. These trials excluded octogenarians
and symptomatic older patients who possibly would have
a different risk of stroke from younger patients when treat-
ed medically. Furthermore, Dr. O’Hara’s manuscript did
not state whether all the strokes observed were in the
hemisphere ipsilateral to an endarterectomy in an octoge-
narian. Therefore, my first question asks whether all your
postoperative strokes were ipsilateral to an endarterecto-
my? Second, did you find that patients who were sympto-
matic were distinguishable from patients who were asymp-
tomatic with respect to late freedom from stroke? My
third question asks how the distribution of symptomatic
versus asymptomatic in your octogenarians, which was
45% to 55%, compares with that distribution in the Cleve-
land Clinic’s patients who were younger than 80 years? I
was intrigued to find that chronic obstructive pulmonary
disease was a highly significant predictor of mortality rate
despite the fact that pulmonary failure was not listed as a
cause of death for any of the patients who were known to
have died. I was even more surprised and intrigued to see
chronic obstructive pulmonary disease as a predictor of
stroke. My fourth question asks you to comment on a pos-
sible mechanism to explain why chronic obstructive pul-
monary disease should be associated with stroke. Fifth and
finally, given a 4.9-fold higher risk of stroke and a 2.3-fold
higher risk of stroke in your study, should one consider
advanced chronic obstructive pulmonary disease a con-
traindication to carotid endarterectomy in octogenarians?
Despite concerns about the declining value of carotid
endarterectomy as age increases, we too have performed
carotid endarterectomy in otherwise vigorous patients as
old as 93 years with no perioperative deaths and gratifying
early and late freedom from stroke in the octogenarian
group.
No clinical study can provide a simple answer for every
patient we evaluate, and I believe clinical judgement will
continue to dominate decision-making once the appropriate
stenosis thresholds have been reached. Furthermore, low
perioperative morbidity rates and mortality rates are essen-
tial if real benefit is to be derived from carotid endarterec-
tomy, most especially for asymptomatic patients. Institu-
tions and surgeons with Dr. O’Hara’s exemplary results can
justify a recommendation for carotid endarterectomy and
selected octogenarians and even nonagenarians. I am grate-
ful to Dr. O’Hara and to the society for the opportunity to
review and comment on this well-analyzed study and well-
written paper, and I commend all of you.
Dr. Patrick J. O’Hara. Dr. Schneider, I appreciate
your kind comments and your questions, and I will
answer them in order. The first question asked whether
all of our strokes were ipsilateral to the endarterectomy,
and the answer is that unfortunately we were not able to
determine, for all of the patients, the hemisphere
involved because of the nature of the study. So, the
answer is that this study encompasses all strokes, and we
do not know really whether they are all ipsilateral or con-
tralateral. This is a shortcoming of this study. Do you
find that symptomatic patients were indistinguishable
from asymptomatic patients with respect to late freedom
of stroke? We were unable to distinguish between symp-
toms versus no symptoms because the difference was not
significant. How is the distribution of symptomatic ver-
sus asymptomatic patients compared with general prac-
tice? I do not have the figures for our general practice,
but my impression is that the distribution is generally the
same. We perform a fair number of carotid endarterec-
tomies in asymptomatic patients who have 80% to 99%
stenosis, very tight carotid lesions, because we believe the
operation is beneficial in general and for the octogenari-
an. So I would say the distribution is about the same. As
to the question regarding the possible mechanism to
explain why chronic obstructive pulmonary disease is
associated with stroke, it is fascinating. The short answer
is that no, we do not know what the mechanism is. The
multivariable analysis shows that chronic obstructive pul-
monary disease is associated with a higher risk of stroke,
but we cannot imply cause and effect. It may be that
what we were measuring as chronic obstructive pul-
monary disease is actually related to another variable that
may influence the stroke rate, so they may not be linked
directly. Thus the short answer is that we do not know,
but certainly we should look into it further. You asked, in
the last question, whether chronic obstructive pulmonary
disease would be a contraindication to endarterectomy,
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given a five-times higher risk of stroke and a higher risk
of death in this study associated with chronic obstructive
pulmonary disease. I suppose it would be a relative con-
traindication. We tried to show this influence by the pro-
portional hazards model that was one of the last slides. It
should factor in as a complement to clinical judgement,
but there is obviously still room for clinical judgement. I
would like to thank you for the questions.
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